Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPureTech Regulatory News (PRTC)

Share Price Information for PureTech (PRTC)

Share Price is delayed by 15 minutes
Get Live Data
125.00    0.80 (0.64%)
Bid:
124.00
Ask:
124.80
Spread: 0.80 (0.645%)
Market Cap: £304.27m
PRTC Live PriceLast checked at - London Stock Exchange

Intraday PureTech Share Chart

Transaction in Own Shares

3 Apr 2023 07:00

RNS Number : 0252V
PureTech Health PLC
03 April 2023
 

3 April 2023

 

PureTech Health plc

 

Transaction in Own Shares

 

PureTech Health PLC (the "Company") announces that it has purchased the following number of its ordinary shares of one pence each through Jefferies International Limited ("Jefferies"), as part of its Share Buyback Programme, details of which were announced on 9 May 2022.

 

Date of purchase:

31 March 2023

Number of ordinary shares purchased:

6,172

Highest price paid per share:

221.00p

Lowest price paid per share:

220.50p

Volume weighted average price paid per share:

220.99p

 

PureTech intends to retain the purchased shares in treasury.

Following the above transaction, the Company will have 11,030,430 ordinary shares in treasury and has 278,437,729 ordinary shares in issue (excluding treasury shares). The total number of voting rights in the Company is therefore 278,437,729 which may be used by shareholders in their calculations to determine if they are required to notify their interest in, or a change to their interest in, PureTech Health plc under the FCA's Disclosure Guidance and Transparency Rules.

 

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018) (the Market Abuse Regulation), detailed information about the individual purchases is available below.

 

About PureTech Health

PureTech is a biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases. The Company has created a broad and deep pipeline through the expertise of its experienced research and development team and its extensive network of scientists, clinicians and industry leaders. This pipeline, which is being advanced both internally and through PureTech's Founded Entities, is comprised of 26 therapeutics and therapeutic candidates, including two (Plenity® and EndeavorRx®) that have received both U.S. FDA clearance and European marketing authorization and a third (KarXT) that will soon be filed for FDA approval, as of the most recent update by the Company. All of the underlying programs and platforms that resulted in this pipeline of therapeutic candidates were initially identified or discovered and then advanced by the PureTech team through key validation points based on unique insights in immunology and drug development.

 

For more information, visit www.puretechhealth.com or connect with us on Twitter @puretechh.

 

Contact:

PureTech

Investor Relations

IR@puretechhealth.com

 

Individual Transactions

 

Transaction Date

Transaction Time

Volume

Price (GBp)

Platform

Transaction Reference Number

31/03/2023

16:22:48

267

221

XLON

00346417423TRLO1.1.1

31/03/2023

16:22:48

1566

221

XLON

00346417422TRLO1.1.1

31/03/2023

16:22:47

272

221

AQXE

00346417404TRLO1.1.1

31/03/2023

16:22:47

7

221

AQXE

00346417403TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417399TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417400TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417397TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417396TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417394TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417392TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417391TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417387TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417389TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417386TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417385TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417382TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417383TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417380TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417378TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417379TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417376TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417375TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417374TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417371TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417372TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417370TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417368TRLO1.1.1

31/03/2023

16:22:47

4

221

AQXE

00346417367TRLO1.1.1

31/03/2023

16:22:47

8

221

AQXE

00346417357TRLO1.1.1

31/03/2023

16:22:47

3

221

AQXE

00346417277TRLO1.1.1

31/03/2023

16:22:47

137

220.5

XLON

00346417263TRLO1.1.1

31/03/2023

16:22:47

104

221

XLON

00346417261TRLO1.1.1

31/03/2023

16:22:47

79

221

XLON

00346417259TRLO1.1.1

31/03/2023

16:22:47

84

221

XLON

00346417256TRLO1.1.1

31/03/2023

16:22:47

77

221

XLON

00346417254TRLO1.1.1

31/03/2023

16:22:47

90

221

XLON

00346417250TRLO1.1.1

31/03/2023

16:22:47

140

221

XLON

00346417252TRLO1.1.1

31/03/2023

16:22:47

100

221

XLON

00346417248TRLO1.1.1

31/03/2023

16:22:47

130

221

XLON

00346417247TRLO1.1.1

31/03/2023

16:22:47

130

221

XLON

00346417244TRLO1.1.1

31/03/2023

16:22:47

150

221

XLON

00346417246TRLO1.1.1

31/03/2023

16:22:47

96

221

XLON

00346417245TRLO1.1.1

31/03/2023

16:22:47

84

221

XLON

00346417242TRLO1.1.1

31/03/2023

16:22:47

535

221

XLON

00346417243TRLO1.1.1

31/03/2023

16:22:47

125

221

XLON

00346417241TRLO1.1.1

31/03/2023

16:22:47

89

221

XLON

00346417240TRLO1.1.1

31/03/2023

16:22:47

67

221

XLON

00346417239TRLO1.1.1

31/03/2023

16:22:47

93

221

XLON

00346417238TRLO1.1.1

31/03/2023

16:22:47

123

221

XLON

00346417236TRLO1.1.1

31/03/2023

16:22:47

79

221

XLON

00346417237TRLO1.1.1

31/03/2023

16:22:47

14

220.5

CHIX

00346417234TRLO1.1.1

31/03/2023

16:22:47

94

221

XLON

00346417235TRLO1.1.1

31/03/2023

16:22:47

7

221

CHIX

00346417232TRLO1.1.1

31/03/2023

16:22:47

7

221

CHIX

00346417233TRLO1.1.1

31/03/2023

16:22:47

111

221

XLON

00346417230TRLO1.1.1

31/03/2023

16:22:47

7

221

CHIX

00346417231TRLO1.1.1

31/03/2023

16:22:47

69

221

XLON

00346417229TRLO1.1.1

31/03/2023

16:22:47

105

221

XLON

00346417228TRLO1.1.1

31/03/2023

16:22:47

132

221

XLON

00346417227TRLO1.1.1

31/03/2023

16:22:47

154

221

XLON

00346417226TRLO1.1.1

31/03/2023

16:22:47

6

220.5

BATE

00346417224TRLO1.1.1

31/03/2023

16:22:47

89

221

XLON

00346417225TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417222TRLO1.1.1

31/03/2023

16:22:47

8

221

BATE

00346417223TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417220TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417219TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417221TRLO1.1.1

31/03/2023

16:22:47

10

220.5

BATE

00346417218TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417216TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417217TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417213TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417214TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417215TRLO1.1.1

31/03/2023

16:22:47

9

221

CHIX

00346417212TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417211TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417210TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417209TRLO1.1.1

31/03/2023

16:22:47

7

221

CHIX

00346417208TRLO1.1.1

31/03/2023

16:22:47

116

221

XLON

00346417206TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417207TRLO1.1.1

31/03/2023

16:22:47

14

221

CHIX

00346417205TRLO1.1.1

31/03/2023

16:22:47

7

221

CHIX

00346417204TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417203TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417202TRLO1.1.1

31/03/2023

16:22:47

7

221

CHIX

00346417201TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417200TRLO1.1.1

31/03/2023

16:22:47

8

221

CHIX

00346417199TRLO1.1.1

31/03/2023

16:22:47

4

220.5

TRQX

00346417197TRLO1.1.1

31/03/2023

16:22:47

9

221

CHIX

00346417198TRLO1.1.1

31/03/2023

16:22:47

3

221

TRQX

00346417196TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417195TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417194TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417192TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417193TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417191TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417189TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417190TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417188TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417187TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417185TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417186TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417183TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417184TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417182TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417181TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417179TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417180TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417178TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417176TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417177TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417175TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417173TRLO1.1.1

31/03/2023

16:22:47

2

221

TRQX

00346417174TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417172TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417171TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417170TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417168TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417169TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417167TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417165TRLO1.1.1

31/03/2023

16:22:47

5

221

BATE

00346417166TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417163TRLO1.1.1

31/03/2023

16:22:46

5

221

BATE

00346417164TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417161TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417162TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417158TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417160TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417152TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417153TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417151TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417150TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417149TRLO1.1.1

31/03/2023

16:22:46

36

221

TRQX

00346417148TRLO1.1.1

31/03/2023

16:22:46

2

221

TRQX

00346417147TRLO1.1.1

31/03/2023

16:22:46

8

221

CHIX

00346417146TRLO1.1.1

31/03/2023

16:22:46

8

221

CHIX

00346417144TRLO1.1.1

31/03/2023

16:22:46

8

221

CHIX

00346417145TRLO1.1.1

31/03/2023

16:22:46

8

221

CHIX

00346417143TRLO1.1.1

31/03/2023

16:22:46

8

221

CHIX

00346417142TRLO1.1.1

31/03/2023

16:22:46

56

221

CHIX

00346417140TRLO1.1.1

31/03/2023

16:22:46

8

221

CHIX

00346417141TRLO1.1.1

31/03/2023

16:22:46

4

221

BATE

00346417139TRLO1.1.1

31/03/2023

16:22:46

50

221

BATE

00346417138TRLO1.1.1

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSFLFVRVRILVIV
Date   Source Headline
29th May 20265:00 pmRNSHolding(s) in Company
27th May 20265:30 pmRNSHolding(s) in Company
22nd May 20265:00 pmRNSHolding(s) in Company
15th May 20267:00 amRNSCorrection - Holding(s) in Company
13th May 202612:00 pmRNS-RPRTC To Showcase Deupirfenidone at ATS Conference
8th May 20267:00 amRNSHolding(s) in Company
7th May 20266:27 pmRNSHolding(s) in Company
1st May 20267:00 amRNSPureTech's Seaport Prices Upsized IPO Nasdaq: SPTX
29th Apr 20267:01 amRNSFinal Results
29th Apr 20267:00 amRNSPRTC Voluntarily Delists Nasdaq Depositary Shares
27th Apr 20266:09 pmRNSHolding(s) in Company
27th Apr 202612:05 pmRNS-RPRTC's Seaport Adds Neuropsychiatry Veteran to BOD
24th Apr 20265:58 pmRNSHolding(s) in Company
22nd Apr 202612:00 pmRNS-RPRTC's Gallop: Positive Ph1 Topline MDS & AML Data
16th Apr 20265:00 pmRNSHolding(s) in Company
16th Apr 20267:00 amRNSHolding(s) in Company
13th Apr 20267:05 amRNSNotice of Results
13th Apr 20267:00 amRNSPRTC's Seaport Files for Proposed Nasdaq IPO
1st Apr 20267:00 amRNSTotal Voting Rights
25th Mar 20266:00 pmRNS-RPRTC’s Seaport: GlyphAllo Paper Published
13th Mar 20264:35 pmRNSPDMR Notification RSU Vesting
2nd Mar 20267:00 amRNSTotal Voting Rights
25th Feb 20267:00 amRNS-RPRTC to Present at Leerink Healthcare Conference
19th Feb 20265:15 pmRNS-RPRTC's Deupirfenidone Granted FDA & EU ODD for IPF
6th Jan 202612:00 pmRNS-RPureTech to Present at the JP Morgan Conference
18th Dec 20257:00 amRNSPureTech Appoints Robert Lyne as CEO
10th Dec 20255:41 pmRNSResults of AGM on June 16, 2025 – Update Statement
10th Dec 20255:30 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RPRTC: Successful FDA Meeting; IPF Phase 3 in 1H26
5th Dec 20256:00 pmRNS-RPRTC's Gallop: Positive Initial Topline AML Data
18th Nov 20255:30 pmRNSHolding(s) in Company
7th Nov 20256:18 pmRNSHolding(s) in Company
3rd Nov 20252:00 pmRNS-RPRTC: New LYT-200 AML Data + Update at ASH
22nd Oct 20257:00 amRNS-RPRTC: New IPF Data Show Benefit in Older Patients
17th Oct 20255:30 pmRNSHolding(s) in Company
14th Oct 20257:00 amRNSHolding(s) in Company
10th Oct 20255:59 pmRNSHolding(s) in Company
9th Oct 20256:10 pmRNSHolding(s) in Company
1st Oct 20257:00 amRNSHolding(s) in Company
29th Sep 20257:00 amRNS-RPRTC: New IPF Data Show Switch Patients Stabilized
24th Sep 20257:00 amRNSPDMR DEALING - PURCHASE OF SHARES
23rd Sep 20255:30 pmRNSHolding(s) in Company
19th Sep 20255:52 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 202512:05 pmRNS-RPRTC's Seaport Advances 2nd Candidate Into Clinic
4th Sep 20255:30 pmRNSHolding(s) in Company
1st Sep 20257:00 amRNSTotal Voting Rights
28th Aug 20257:00 amRNSHalf-year Report
21st Aug 202512:00 pmRNS-RPureTech Showcases Differentiated IPF Strategy
18th Aug 20257:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.